ArticleTranslational lung cancer research2020

Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis.

Hengrui Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.